UBS Group AG - INNATE PHARMA S A ownership

Back to all holdings Add to watchlist

INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 14 filers reported holding INNATE PHARMA S A in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS Group AG ownership history of INNATE PHARMA S A
ValueSharesWeighting
Q3 2023$369
-17.8%
1460.0%0.00%–
Q2 2023$449
-87.5%
146
-88.4%
0.00%–
Q1 2023$3,588
+558.3%
1,259
+762.3%
0.00%–
Q4 2022$545
-93.9%
146
-96.8%
0.00%–
Q3 2022$9,000
+12.5%
4,505
+52.4%
0.00%–
Q2 2022$8,000–2,956–0.00%–
 Download
Other shareholders
INNATE PHARMA S A shareholders Q2 2022
NameSharesValueWeighting ↓
BANK OF AMERICA CORP /DE/ 46,749$133,2350.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 61,899$1760.00%
MORGAN STANLEY 48,722$138,8580.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 13,315$37,8150.00%
Steward Partners Investment Advisory, LLC 500$1,4250.00%
Optiver Holding B.V. 224,097$636,4350.00%
BARCLAYS PLC 412$10.00%
ROYAL BANK OF CANADA 124$00.00%
UBS Group AG 1,259$3,5880.00%
View complete list of INNATE PHARMA S A shareholders